BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33717085)

  • 1. Analysis of the Characteristics of TIGIT-Expressing CD3
    Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
    Front Immunol; 2021; 12():602492. PubMed ID: 33717085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
    Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
    Front Immunol; 2018; 9():2341. PubMed ID: 30364127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Dysfunctions of CD56
    Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
    Front Immunol; 2021; 12():811091. PubMed ID: 35069597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects.
    Lima JF; Oliveira LMS; Pereira NZ; Duarte AJS; Sato MN
    Sci Rep; 2017 Apr; 7(1):524. PubMed ID: 28373665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
    Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
    J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing roles of CD3 + CD8 low T cells in combating HIV-1 infection.
    Zhang X; Wang X; Qin L; Lu X; Liu Z; Li Z; Yuan L; Wang R; Jin J; Ma Z; Wu H; Zhang Y; Zhang T; Su B
    Chin Med J (Engl); 2023 Feb; 136(4):433-445. PubMed ID: 36580634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
    Vendrame E; Seiler C; Ranganath T; Zhao NQ; Vergara R; Alary M; Labbé AC; Guédou F; Poudrier J; Holmes S; Roger M; Blish CA
    AIDS; 2020 May; 34(6):801-813. PubMed ID: 32028328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
    AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKG2C+ natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV.
    Song T; Li L; Su B; Liu L; Liu Y; Yang X; Zhang Q; Guo N; Zhang T; Sun G; Wu H
    Medicine (Baltimore); 2020 May; 99(18):e20073. PubMed ID: 32358389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer.
    Peng YP; Xi CH; Zhu Y; Yin LD; Wei JS; Zhang JJ; Liu XC; Guo S; Fu Y; Miao Y
    Oncotarget; 2016 Oct; 7(41):66586-66594. PubMed ID: 27626490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-9 Expression Defines a Subpopulation of NK Cells with Impaired Cytotoxic Effector Molecules but Enhanced IFN-γ Production, Dichotomous to TIGIT, in HIV-1 Infection.
    Motamedi M; Shahbaz S; Fu L; Dunsmore G; Xu L; Harrington R; Houston S; Elahi S
    Immunohorizons; 2019 Nov; 3(11):531-546. PubMed ID: 31732662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56
    Ziegler AE; Fittje P; Müller LM; Ahrenstorf AE; Hagemann K; Hagen SH; Hess LU; Niehrs A; Poch T; Ravichandran G; Löbl SM; Padoan B; Brias S; Hennesen J; Richard M; Richert L; Peine S; Oldhafer KJ; Fischer L; Schramm C; Martrus G; Bunders MJ; Altfeld M; Lunemann S
    Front Immunol; 2023; 14():1117320. PubMed ID: 36845105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
    Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56
    Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
    J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.